ZNF75A inhibitors are a specialized class of compounds that target zinc finger protein 75A (ZNF75A), a transcription factor that belongs to the large family of zinc finger proteins. ZNF75A, like other zinc finger proteins, contains zinc finger domains, which are structural motifs that enable the protein to bind to specific DNA sequences and regulate the transcription of target genes. These domains require the coordination of zinc ions to maintain their structural integrity, allowing ZNF75A to interact with particular regions of DNA. ZNF75A inhibitors function by disrupting this interaction, either by directly affecting the protein's ability to bind to DNA or by destabilizing its structure. Such interference can lead to altered gene expression, impacting a variety of cellular pathways controlled by ZNF75A.
These inhibitors can operate through different mechanisms to inhibit the activity of ZNF75A. Some inhibitors act by chelating the zinc ions that are essential for the structural stability of the zinc finger motifs, thus preventing ZNF75A from maintaining its functional conformation. Without these zinc ions, the protein loses its ability to bind DNA with the necessary specificity, resulting in a disruption of its regulatory functions. Other inhibitors may act by interfering with the protein's interactions with other molecules or transcriptional machinery, blocking the formation of complexes necessary for gene regulation. The study of ZNF75A inhibitors provides valuable insight into how specific transcription factors, such as ZNF75A, contribute to the regulation of gene networks, as well as how modulating their activity can impact cellular processes such as gene expression, differentiation, and cellular homeostasis. Understanding the function and inhibition of ZNF75A sheds light on the broader role of zinc finger proteins in cellular regulation and genetic control.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A nucleoside analog that incorporates into DNA and RNA, can demethylate DNA, potentially altering the expression of ZNF75A. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
A hypomethylating agent that can lead to DNA demethylation and may affect ZNF75A gene expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
An antineoplastic antibiotic that binds to GC-rich DNA sequences, possibly affecting ZNF75A transcription. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
A compound that can raise endosomal pH and affect gene expression, potentially influencing ZNF75A. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
A diterpene triepoxide that can inhibit transcription factors and might affect ZNF75A expression. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $315.00 | ||
A CDK4/6 inhibitor that can arrest cell cycle progression, potentially affecting ZNF75A levels due to altered cell cycle dynamics. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
A BET bromodomain inhibitor that can alter chromatin structure and gene expression, possibly influencing ZNF75A expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
A histone deacetylase inhibitor that can change chromatin structure and gene expression, potentially affecting ZNF75A expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
A proteasome inhibitor that can lead to the accumulation of regulatory proteins, possibly altering ZNF75A function. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A proteasome inhibitor that might influence ZNF75A function by affecting protein degradation pathways. | ||||||